Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Amgen) Feb 4, 2016 - Amgen today announced that the results of a prespecified interim analysis showed that the primary endpoint of improved overall survival was met in the Phase 3 TOWER study.
read corporate press release »
(NIH) Feb 5, 2015 - National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more types of cancer.
read press release »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
Ipsos has 2 jobs posted.
Seattle Genetics has 1 job posted.
Bayer Pharmaceuticals has 1 job posted.
Touchpoint Solutions has 1 job posted.
Check out the OBR Job Board here.